Adult Onset Still's Disease

Also known as: Adult's Still Disease / Adult-Onset Still´s Disease / Adult-Onset Still Disease / Adult Onset Still Disease / Adult-Onset Still's Disease / Still's disease adult onset / Still's Disease, Adult-Onset / Still Disease, Adult-Onset / AOSD / Adult onset Still's disease (disorder) / Juvenile rheumatoid arthritis with systemic onset / Still's disease / Systemic onset juvenile chronic arthritis (disorder) / Juvenile-Onset Still Disease

DrugDrug NameDrug Description
DB06168CanakinumabAn interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial Mediterranean Fever (FMF), and also to treat active Systemic Juvenile Idiopathic Arthritis (SJIA).
DrugDrug NameTargetType
DB06168CanakinumabInterleukin-1 betatarget
DrugDrug NamePhaseStatusCount
DB00026Anakinra2Completed1
DB00993Azathioprine2Completed1
DB06168Canakinumab2Terminated1
DB14724Emapalumab2Completed1
DB01097Leflunomide2Completed1
DB00563Methotrexate2Completed1
DB06372Rilonacept2Completed1
DB14858Tadekinig alfa2Completed1
DB06273Tocilizumab2Unknown Status1
DB00026Anakinra3Recruiting1
DB00026Anakinra3Terminated1
DB06168Canakinumab3Active Not Recruiting1
DB16396Goflikicept3Withdrawn1